查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016688

細胞分離市場規模、佔有率、趨勢和預測：按方法、細胞類型、產品、應用、最終用途和地區分類，2026-2034 年

Cell Isolation Market Size, Share, Trends and Forecast by Technique, Cell Type, Product, Application, End Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球細胞分離市場規模達177億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到541億美元，2026年至2034年的複合年成長率（CAGR）為12.85%。目前，北美市場佔據主導地位，預計到2025年將佔據超過39.9%的市場。慢性病盛行率的上升、對高效細胞分離方法的需求、再生醫學和細胞療法需求的成長以及生物技術和生命科學領域投資的增加，都是推動市場成長的主要因素。

再生醫學領域的擴張以及對高效細胞分離技術日益成長的需求正在推動全球細胞分離市場的成長。慢性疾病的日益普遍催生了對先進細胞治療方法的需求，從而推動了整體市場成長。因此，生物技術和生命科學領域的投資和資金籌措增加，促進了研發活動，進一步增強了市場動能。對個人化醫療日益成長的需求進一步增加了對特定細胞分離方法的需求，從而推動了市場成長。對癌症研究的日益關注以及對標靶治療的需求也促進了市場成長。此外，人口老化以及學術機構和產業界之間的快速合作也進一步推動了市場發展。

在美國，生物技術和生物製藥研究的顯著進展正在推動市場發展。對個人化和再生醫學日益成長的需求，以及癌症等慢性疾病盛行率的上升，凸顯了精準細胞分離方法的重要性。政府資助和私營部門對醫學研究的投資共同推動了細胞分離技術的創新。此外，癌症和自體免疫疾病的細胞療法和免疫療法的蓬勃發展也促進了市場擴張。大型製藥和生物技術公司的存在，以及完善的醫療保健基礎設施，正在加速細胞分離技術在臨床和研究領域的應用。例如，2024年4月，致力於開發業界領先的個人化藥物自動化生產系統的機器人公司Multiply Labs與全球領先的生命科學研究工具和服務供應商金斯瑞生物技術股份有限公司（GenScript）宣佈建立戰略合作夥伴關係，旨在實現細胞療法生產中細胞分離流程的自動化，從而簡化這一耗時的步驟。

細胞分離市場的發展趨勢：

再生醫學領域正在不斷發展

再生醫學領域的蓬勃發展與全球細胞分離市場的成長密切相關。再生醫學致力於利用細胞修復受損組織和器官的潛力，進而革新醫療模式。研究日益凸顯了再生醫學的必要性。高純度分離特定類型的細胞是確保再生醫學手術成功的關鍵。為了滿足這項需求，最新的細胞分離技術正在不斷研發和應用，推動市場成長。世界各地的相關機構正在製定政策和計劃，以進一步推動該領域的發展。例如，美國政府責任署（GAO）提出了11項政策建議，旨在應對再生醫學面臨的挑戰並提升其益處。

慢性病增多

慢性病盛行率的激增凸顯了對先進細胞療法的迫切需求，從而推動了細胞分離市場的顯著成長。糖尿病、心血管疾病和神經退化性疾病等慢性病對全球醫療保健系統構成重大挑戰。根據美國衛生與公共服務部估計，約有1.29億美國人患有至少一種嚴重的慢性病，​​包括癌症、糖尿病、高血壓、心臟病和肥胖症。患有多種慢性病的美國人數量正在增加，42%的人患有兩種或兩種以上疾病，12%的人患有至少五種疾病。慢性病給個人帶來沉重負擔，並對美國醫療保健系統造成重大影響。每年4.1兆美元的醫療支出中，約90%用於精神疾病和慢性病的治療和管理。細胞療法透過提供再生醫學和個人化治療方案，在應對這些挑戰方面具有巨大潛力。為了最大限度地發揮這些治療方法的潛力，分離出具有活性且功能完整的細胞至關重要。這種需求促使人們加強研發力度，開發出能夠滿足細胞治療多樣化需求的高效細胞分離方法，進而塑造市場趨勢。

生物技術和生命科學領域的資金籌措和投資

生物技術和生命科學領域的強勁資金籌措和發展正推動細胞分離市場的成長。過去三年，全球生技產業的創業投資（VC）資金籌措激增。例如，根據印度投資網格（Indian Investment Grid）的數據，光是印度就有15個生技領域的投資項目，總額達371萬美元。私人投資者、政府和創投家都認知到細胞分離技術創新進步在藥物研發和疾病治療等各種應用領域的巨大潛力。因此，大量資金正投入到旨在開發和改進細胞分離技術的研發舉措中。這些資金的湧入不僅進一步加速了新方法的開發，也推動了先進細胞分離產品的商業化。科學研究和投資的協同效應正在驅動市場發展，使其處於技術和醫學創新的前沿。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球細胞分離市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依方法

  • 離心分離
  • 表面標記
  • 過濾

第7章 市場區隔：依細胞類型分類

  • 人類細胞
  • 動物細胞

第8章 市場區隔：依產品分類

  • 消耗品
    • 主要部分
      • 試劑、試劑盒、培養基及血清
      • 珠
      • 一次性產品
  • 裝置
    • 主要部分
      • 離心機
      • 流式細胞儀
      • 過濾系統
      • 磁性細胞分離系統

第9章 市場區隔：依應用領域分類

  • 生物分子的分離
  • 治療
  • 幹細胞研究
  • 癌症研究
  • 組織再生
  • 體外診斷試劑

第10章 市場區隔：依最終用途分類

  • 生物技術和生物製藥公司
  • 醫院/診斷檢查室
  • 研究機構和研究單位
  • 其他

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

第16章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Alfa Laval AB
    • Becton Dickinson and Company
    • Beckman Coulter Inc.（Danaher Corporation）
    • Bio-Rad Laboratories Inc.
    • General Electric Company
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • pluriSelect Life Science UG（haftungsbeschrankt）& Co. KG
    • Roche Holding AG
    • STEMCELL Technologies Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A3942

The global cell isolation market size reached USD 17.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 54.1 Billion by 2034, exhibiting a growth rate (CAGR) of 12.85% during 2026-2034. North America, currently dominates the market, holding a market share of over 39.9% in 2025 . An increase in chronic illnesses, the necessity for effective isolation methods, the rising demand for regenerative medicine and cell-based therapies, and rising investments in biotechnology and life sciences are factors facilitating the market growth.

The expanding field of regenerative medicine and the escalating need for efficient cell isolation techniques influence the global cell isolation market growth. The increasing prevalence of chronic diseases in turn creates a demand for advanced cell-based therapies, promoting the market's overall growth. Consequently, more investment and funding in the biotechnology and life sciences segments fuel research and development (R&D) activities, which further increase the market momentum. The increasing demand for personalized medicine, further boosts the requirement for specific cell isolation methods, thus propelling the market growth. The rising emphasis on cancer research and the demand for targeted therapies are contributing to the market growth. The market is further driven by the increasing aging population base and rapid collaborations between academic institutions and industry players.

In the United States, the market is driven by significant advancements in biotechnology and biopharmaceutical research. An increased demand for personalized medicine and regenerative therapies, along with rising incidences of chronic diseases like cancer, boosts the need for precise cell isolation methods. Government funding for healthcare research, coupled with private sector investments, supports innovation in cell isolation technologies. Furthermore, the growing trend toward cell-based therapies and immunotherapies in cancer and autoimmune diseases is fueling market expansion. The presence of leading pharmaceutical and biotechnology companies, along with robust healthcare infrastructure, also accelerates the adoption of cell isolation technologies in clinical and research settings. For instance, in April 2024, Multiply Labs, a robotics company creating industry-leading automated manufacturing systems to produce customized drugs, and GenScript Biotech Corporation (GenScript), one of the world's top suppliers of life-science research tools and services, announced a strategic partnership centered on automating the cell isolation phase of cell therapy manufacturing to simplify this time-consuming procedure.

CELL ISOLATION MARKET TRENDS:

Expanding Field of Regenerative Medicine

The expanding field of regenerative medicine is closely related to the expansion of the worldwide cell isolation market. Regenerative medicine highlights employing the potential of cells to repair broken tissues and organs, thereby modernizing medical treatment paradigms. The need for accurate and effective cell separation methods is becoming more and more clear as researchers investigate regenerative medicines. Isolation of specialised cell types with high purity is vital to guarantee the accomplishment of regenerative procedures. Modern cell separation technologies are developed and adopted in response to this demand, which fuels market growth. Concerning bodies across the globe are making policies and schemes to further advance the field. For instance, 11 policy proposals were created by the US Government Accountability Office to help address the issues or improve the advantages of regenerative medicine.

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases has ignited a pressing need for advanced cell-based therapies, thereby driving significant growth in the cell isolation market. Chronic diseases like diabetes, cardiovascular disease, and neurodegenerative disorders present significant obstacles for healthcare systems around the world. According to the US Department of Health and Human Services, an estimated 129 Million Americans endure at least one severe chronic illness, such as cancer, diabetes, hypertension, heart disease, and obesity. The number of Americans living with numerous chronic illnesses is rising; 42% have two or more, and 12% have at least five. Chronic illness has a significant influence on the US health care system in addition to its personal toll. Approximately 90% of the USD 4.1 Trillion spent on health care each year goes towards treating and managing mental health issues and chronic illnesses. Cell-based therapies secure massive potential in addressing these tasks by offering regenerative and personalized treatment methods. In order to harness the potential of such therapies, the isolation of viable and functionally intact cells is vital. This imperative has led to intensified research and development efforts to innovate efficient cell isolation methods that cater to the diverse needs of cell-based treatments, shaping the trajectory of the market.

Funding and Investments in Biotechnology and Life Sciences Sectors

Strong funding and developments in the biotechnology and life sciences sectors are driving the market for cell isolation upward. The biotechnology industry across the globe has seen a surge in venture capital (VC) funding during the last three years. For instance, as per the data by Indian Investment Grid, India alone has 15 investment projects totalling USD 3.71 Million in the biotechnology subsector. Private investors, governments, and venture capitalists understand how revolutionary advances in cell separation techniques can be for various uses, such as medication development and illness treatment. Thus, significant financial funds into research initiatives directed towards developing and improving the technologies of cell isolation. Such an inflow of money can further develop new methods, as well as lead to the commercialization of advanced cell isolation products. The market is driven forward by the combination of scientific research and financial investments, placing it at the forefront of technical and medical innovation.

CELL ISOLATION INDUSTRY SEGMENTATION:

Analysis by Technique:

  • Centrifugation
  • Surface Marker
  • Filtration

Centrifugation leads the market with around 43.8% of market share in 2025. Important factors supporting the expansion of the centrifugation segment include rising awareness of the diversity of centrifugation procedures, which may isolate a variety of cell types, from subcellular organelles to blood components. Technological improvements in centrifuges, resulting in faster processing and better separation efficiency, also continue to support their wide adoption. The proven reliability and ease of use ensure that the method finds favor with an extensive user base of researchers and clinicians. Centrifugation further meets compatibility standards with the varying sample sizes and volumes, thus being flexible enough to provide for a multitude of experimental needs. Its compatibility with numerous sample sources, such as blood, tissues, and cell cultures, situates centrifugation as a versatile and significant technique in cell isolation workflows, driving its segment growth within the broader market landscape.

Analysis by Cell Type:

  • Human Cells
  • Animal Cells

Animal cells leads the market with around 53.7% of market share in 2025. The growing use of animal cells in drug development and scientific research is the main factor driving the expansion of animal cell isolation. The increasing demand for effective separation techniques has also been driven by the need for biopharmaceuticals, increasingly using animal cell cultures for production. The increasing regenerative medicine use encourages the investigation of treatments relying on animal cells and requires optimized protocols for isolation. Furthermore, the increase in chronic diseases requires advanced disease modeling utilizing animal cells, further driving the segment's growth. Technological developments in cell isolation techniques support market growth by meeting the complex needs of animal cell isolation. Partnerships between academic institutions and industry players enable knowledge discussion, thereby contributing to innovative resolutions in this segment.

Analysis by Product:

  • Consumables
    • Reagents, Kits, Media and Sera
    • Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Flow Cytometers
    • Filtration Systems
    • Magnetic-activated Cell Separator Systems

Consumables lead the market with around 62.2% of market share in 2025. The consumables segment in the market is driven by the increasing adoption of cell-based therapies and regenerative medicine leading to a boost in demand for consumable products for cell isolation procedures. The demand for effective and reliable consumables including reagents, kits, and disposables is growing as clinicians and researchers endeavor to channel the potential of cell therapies. The increasing incidences of chronic conditions have emphasized personalized medicine and precision treatment, compelling specific consumables for isolating target cell populations. Advances in consumable technologies such as better labeling and tagging agents have improved the efficiency and precision of cell isolation. Furthermore, collaborations between research institutions and consumable manufacturers have driven innovation, leading to the development of specialized products tailored to diverse research needs.

Analysis by Application:

  • Biomolecule Isolation
  • Therapeutics
  • Stem Cell Research
  • Cancer Research
  • Tissue Regeneration
  • In-Vitro Diagnostics

Biomolecule isolation leads the market with around 38.7% of the market share in 2025. The major driver for the increase in this segment is the growing field of proteomic and genomic research. The need to extract biomolecules for diagnosis and treatment is increasing because of the growing interest in personalized medicine. Furthermore, biomolecule isolation has become a prerequisite for drug discovery and development of pharmaceutical and biotechnology companies. Technological advancements, particularly in automation and microfluidics, enhance the efficiency and scalability of isolation methods, further driving market growth. Partnerships and collaborations among market players and academic institutions create a knowledge exchange for innovative isolation solutions. This provides impetus to segmental growth as much from rising demand for biomolecules for research applications as it does from the biopharmaceutical industry.

Analysis by End Use:

  • Biotechnology and Biopharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Others

Research laboratories and institutes lead the market with around 49.2% of the market share in 2025. The growth of the research laboratories and institutes segment is boosted by the increasing landscape of scientific discovery, which has pushed the demand for cutting-edge tools. Additionally, the growing emphasis on improvements in the biological sciences and healthcare fields calls for effective cell isolation methods, which is propelling market expansion. Partnerships between academia and industry strengthen research capabilities, encouraging the need for high-quality cell isolation tools. In line with this, rising funding and grants focus sources toward research institutions, aiding investment in advanced isolation methodologies. Additionally, the vigorous nature of research demands flexible solutions, boosting the uptake of customizable cell isolation products. Furthermore, the continuous evolution of drug discovery and development deepens the dependence on robust cell isolation for accurate experimentation.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 39.9%. The region's strong healthcare system and significant research investment are the main drivers of North America's cell isolation market expansion. Furthermore, the need for precise cell-based treatments is fueled by the rise of chronic illnesses like diabetes and cardiovascular conditions, which encourages the use of effective isolation techniques. In line with this, the presence of major biotechnology and pharmaceutical players, coupled with strong research partnerships between academia and industry, promotes technological innovation. Additionally, research and development activities are supported by significant funding from both public and private organizations, which encourages the market's growth. Aside from this, the need of accurate cell separation is increased by North America's growing emphasis on personalized medicine and regenerative medicines. North America's dominant position in the global market is further enhanced by the region's regulatory framework and strict quality standards, which foster the commercialization of cutting-edge cell isolation products.

KEY REGIONAL TAKEAWAYS:

UNITED STATES CELL ISOLATION MARKET ANALYSIS

Improvements in biomedical research and the rising need for personalised therapy are driving the US cell isolation market. With the help of organisations like the National Institutes of Health (NIH), which gave out nearly USD 47 Billion in research grants in 2023, the United States is at the forefront of life sciences innovation. The use of cell therapy, especially CAR-T therapies, to treat illnesses like cancer has grown in popularity, thereby increasing the need for effective cell isolation technologies. Since isolated cells are essential for creating regenerative therapies, the market is also growing because of an increase in chronic diseases including diabetes and autoimmune disorders. With more than 20,000 current studies involving cell isolation technologies, the increasing prevalence of clinical trials suggests increased market activity. Additionally, the necessity for sophisticated cell processing techniques is highlighted by the growth of biosciences in the country. According to data from the Biotechnology Innovation Organization, the biosciences sector's overall economic impact on the US economy in 2021, as determined by total output, was USD 2.9 trillion. The United States also has a strong network of academic and research institutions, which promotes innovation in cell separation methods like magnetic-activated cell sorting (MACS) and microfluidics. Market expansion is further accelerated by the Food and Drug Administration's support for cell-based therapies and regenerative medicine. This is furthered with the creation of innovative cell separation solutions by businesses like BD Biosciences and Thermo Fisher Scientific, which, in turn, is contributing to the market growth.

EUROPE CELL ISOLATION MARKET ANALYSIS

The growing frequency of infectious and chronic diseases, along with rising investments in healthcare innovation, are driving the cell isolation market in Europe. The use of cell isolation methods is accelerated by the substantial funding of biomedical research provided by the European Union's Horizon Europe initiative, which has a Euro 95.5 Billion (USD 100 Billion) budget (2021-2027). The market is growing because of the region's emphasis on cell-based treatments for neurological illnesses and cancer. France, Italy, and Germany are leading centers with a significant number of stem-cell transplants. According to data from the European Union, Germany had the highest rate of stem cell transplants among EU members in 2018 (9.6 per 100,000 population), closely followed by Italy (9.4). The Netherlands (8.4; 2017 statistics), Belgium (8.4), Sweden (8.2), and France (8.6 per 100,000 population) came next. The market expansion is also supported by regulatory frameworks that support advanced therapeutics, such as the Advanced Therapy Medicinal Products (ATMP) classification system established by the European Medicines Agency. Furthermore, the need for cell-based diagnostics and therapies is fuelled by Europe's ageing population, which is expected to account for 28% of the continent's total population by 2030.

ASIA PACIFIC CELL ISOLATION MARKET ANALYSIS

A major market for cell isolation is developing in Asia-Pacific as a result of rising healthcare spending and an increased emphasis on regenerative medicine. China and India are significant contributors; the biotechnology sector in China is expanding at a rate of more than 15% per year, as per an industrial report. Government initiatives such as the "Made in China 2025" plan showcase advancements in biopharmaceuticals and cellular therapies. Japan is also at the forefront, with approved induced pluripotent stem cell (iPSC)-based treatments, which has raised demand for cell isolation. In line with this, the Biotechnology Industry Research Assistance Council (BIRAC), a non-profit Section 8, Schedule B, Public Sector Enterprise established by the Department of Biotechnology (DBT), Government of India, has a flagship program called the "Biotechnology Ignition Grant Scheme (BIG)" that identifies and funds innovative ideas in the biotech industry, further augmenting the research in this field. Market expansion is further accelerated by the region's growing interest in precision medicine and the rising incidence of infectious diseases. Cell isolation methods are also more widely available due to the region's economic production of consumables and reagents.

LATIN AMERICA CELL ISOLATION MARKET ANALYSIS

Growing research into infectious diseases like dengue and Zika is driving the demand for cell isolation in Latin America. With the help of government programs to improve the infrastructure for biomedical research, Brazil and Mexico are the leaders in the region. Cell isolation technologies are becoming more and more popular, partly due to the growth of biobanks and stem cell research initiatives, particularly in Brazil. International partnerships with research institutes in North America and Europe have also made cutting-edge technologies more accessible. Opportunities for cell-based therapeutics that target chronic diseases like diabetes and cardiovascular ailments are created by the region's growing healthcare market. As per the data by International Trade Administration, Brazil is the largest healthcare market in Latin America and spends 9.47% of its GDP on healthcare, which represents USD 161 Billion.

MIDDLE EAST AND AFRICA CELL ISOLATION MARKET ANALYSIS

The rising prevalence of chronic illnesses and infectious disorders is driving growth in the Middle East and Africa (MEA) cell isolation market. In the MENA region, cardiovascular diseases-which include heart disease and stroke-are the main cause of death. According to the Global Burden of Disease Study, over 810,000 people died from ischemic heart disease and over 370,000 from stroke in the region in 2019. In the MENA region, cancer is becoming a bigger concern. It was projected that the region will see approximately 274,000 cancer-related fatalities and almost 461,000 new cancer cases in 2020. Breast, lung, colorectal, and prostate cancers were the most common types. Respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, are prevalent in MENA. COPD itself reported for approximately 3.2 million disability-adjusted life years (DALYs) lost in 2019. To solve healthcare issues, nations like the UAE and South Africa are investing in biotechnology and regenerative medicine. The use of cell isolation techniques is increasing because of partnerships with international research organisations and projects to build cutting-edge labs. The industry is expanding due to developments in immunotherapy and the increased emphasis on stem cell banking. The market's steady growth in the area is further facilitated by investments in healthcare infrastructure and encouraging government initiatives.

COMPETITIVE LANDSCAPE:

The cell isolation market's competitive environment is characterized by dynamic elements that influence industry dynamics. Intense research and development (R&D) activities ensure continuous innovation that results in the introduction of the latest cell isolation technologies. Market players aim to broaden their product portfolios offering a range of isolation solutions ranging from various cell types and applications. Partnerships among industry and academia promote collaborative advancement towards technological breakthroughs. Regulatory compliance and quality standards remain pivotal in this landscape, influencing market entry and expansion strategies. As the landscape evolves, there is also a growing focus on automation and the incorporation of cutting-edge methods to increase isolation repeatability and efficiency. As the market gains traction due to rising medical needs and scientific developments, competition deepens, facilitating players to distinguish through product efficacy, reliability, and versatility while striving to address the ever-evolving demands of the research and healthcare industries.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Alfa Laval AB
  • Becton Dickinson and Company
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Roche Holding AG
  • STEMCELL Technologies Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What is cell isolation?

2. How big is the cell isolation market?

3. What is the expected growth rate of the global cell isolation market during 2026-2034?

4. What are the key factors driving the global cell isolation market?

5. What is the leading segment of the global cell isolation market based on the technique?

6. What is the leading segment of the global cell isolation market based on cell type?

7. What is the leading segment of the global cell isolation market based on product?

8. What is the leading segment of the global cell isolation market based on application?

9. What is the leading segment of the global cell isolation market based on end use?

10. What are the key regions in the global cell isolation market?

11. Who are the key players/companies in the global cell isolation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Isolation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 Centrifugation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Surface Marker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Filtration
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Cell Type

  • 7.1 Human Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Animal Cells
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Reagents, Kits, Media and Sera
      • 8.1.2.2 Beads
      • 8.1.2.3 Disposables
    • 8.1.3 Market Forecast
  • 8.2 Instruments
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Centrifuges
      • 8.2.2.2 Flow Cytometers
      • 8.2.2.3 Filtration Systems
      • 8.2.2.4 Magnetic-activated Cell Separator Systems
    • 8.2.3 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomolecule Isolation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Stem Cell Research
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cancer Research
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Tissue Regeneration
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 In-Vitro Diagnostics
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Biotechnology and Biopharmaceutical Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostic Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Laboratories and Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Alfa Laval AB
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 General Electric Company
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Merck KGaA
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Miltenyi Biotec B.V. & Co. KG
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Roche Holding AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 STEMCELL Technologies Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Terumo Corporation
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Isolation Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Isolation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cell Isolation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Cell Isolation Market: Breakup by Technique (in %), 2025
  • Figure 5: Global: Cell Isolation Market: Breakup by Cell Type (in %), 2025
  • Figure 6: Global: Cell Isolation Market: Breakup by Product (in %), 2025
  • Figure 7: Global: Cell Isolation Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Cell Isolation Market: Breakup by End Use (in %), 2025
  • Figure 9: Global: Cell Isolation Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Cell Isolation (Centrifugation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Cell Isolation (Centrifugation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Cell Isolation (Surface Marker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Cell Isolation (Surface Marker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Cell Isolation (Filtration) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Cell Isolation (Filtration) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Cell Isolation (Human Cells) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Cell Isolation (Human Cells) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Cell Isolation (Animal Cells) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Cell Isolation (Animal Cells) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Cell Isolation (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Cell Isolation (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Cell Isolation (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Cell Isolation (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Cell Isolation (Biomolecule Isolation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Cell Isolation (Biomolecule Isolation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Cell Isolation (Therapeutics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Cell Isolation (Therapeutics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Cell Isolation (Stem Cell Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Cell Isolation (Stem Cell Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Cell Isolation (Cancer Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Cell Isolation (Cancer Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Cell Isolation (Tissue Regeneration) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Cell Isolation (Tissue Regeneration) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Cell Isolation (In-Vitro Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Cell Isolation (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Cell Isolation (Research Laboratories and Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Cell Isolation (Research Laboratories and Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Cell Isolation (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Cell Isolation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: North America: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: North America: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: United States: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: United States: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Canada: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Canada: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Asia-Pacific: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Asia-Pacific: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: China: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: China: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Japan: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Japan: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: India: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: India: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: South Korea: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: South Korea: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Australia: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Australia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Indonesia: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Indonesia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Europe: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Europe: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Germany: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Germany: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: France: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: France: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: United Kingdom: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: United Kingdom: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Italy: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Italy: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Spain: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Spain: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Russia: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Russia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Others: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Latin America: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Latin America: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Brazil: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Brazil: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Mexico: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Mexico: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Others: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Middle East and Africa: Cell Isolation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Middle East and Africa: Cell Isolation Market: Breakup by Country (in %), 2025
  • Figure 92: Middle East and Africa: Cell Isolation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Global: Cell Isolation Industry: SWOT Analysis
  • Figure 94: Global: Cell Isolation Industry: Value Chain Analysis
  • Figure 95: Global: Cell Isolation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Isolation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cell Isolation Market Forecast: Breakup by Technique (in Million USD), 2026-2034
  • Table 3: Global: Cell Isolation Market Forecast: Breakup by Cell Type (in Million USD), 2026-2034
  • Table 4: Global: Cell Isolation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 5: Global: Cell Isolation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Cell Isolation Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 7: Global: Cell Isolation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Cell Isolation Market: Competitive Structure
  • Table 9: Global: Cell Isolation Market: Key Players